Several studies have demonstrated that increased CXCL10 expression correlates with improved prognosis in various human cancers, including high‐grade serous ovarian carcinoma, colorectal cancer (CRC), hepatocellular carcinoma, and breast carcinoma [15, 16, 17, 18]. Here, CXCL10 is linked to colorectal carcinoma.